# TOPIC 419 "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY"

> **NIH NIH N43** · CARE PROGRESS, LLC · 2021 · $399,951

## Abstract

This research project seeks to create novel software to enable oncology providers to more easily identify cancer patients who could benefit from somatic, next-generation sequencing. It will also help providers interpret and explain results, which could alter clinical decision-making, including identifying potential therapeutic targets, ultimately improving clinical outcomes and enhancing patient-centered care.

## Key facts

- **NIH application ID:** 10492890
- **Project number:** 75N91021C00020-0-9999-1
- **Recipient organization:** CARE PROGRESS, LLC
- **Principal Investigator:** HOWARD ISENSTEIN
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $399,951
- **Award type:** —
- **Project period:** 2021-09-16 → 2022-06-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10492890

## Citation

> US National Institutes of Health, RePORTER application 10492890, TOPIC 419 "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" (75N91021C00020-0-9999-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10492890. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*